Caris Life Sciences, Inc. Share Price & Technical Analysis
CAI · $15.94 (+1.53%)
Healthcare / Biotechnology
$15.94
+1.53%
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms. The company's molecular intelligence product portfolio includes MI Profile Platform, a whole exome…
Price chart
Seasonality
May has 0 positive and 1 negative years (last 2 years shown)
-49% return in 2026, 14% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -14% | -12% | -9% | 1% | -14% | – | – | – | – | – | – | – | -49% |
| 25 | – | – | – | – | – | -1% | 6% | 38% | -20% | 0% | -16% | 7% | 14% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms. The company's molecular intelligence product portfolio includes MI Profile Platform, a whole exome sequencing (WES)/ whole transcriptome sequencing (WTS) tissue-based molecular profiling solutions; Caris Assure Platform WES/WTS blood-based molecular profiling solutions; Precision Whole Genome Platform, a whole genome sequencing (WGS) blood- and tissue-based profiling solutions; and Caris Detect, a WGS-based multi-cancer early detection solution; Caris WGS MRD a WGS and digital droplet polymerase reaction-based minimal residual disease solution; and Caris ChromoSeq, a WGS and WTS based assay for therapy selection in hematological cancers. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company provides its precision oncology solutions to customers, such as hospitals, institutions and patients. The company was founded in 2008 and is headquartered in Irving, Texas.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$4.55B
P/E ratio
—
52W high
$42.50
52W low
$14.19
Volume
23,68,494
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Caris Life Sciences, Inc. share price today?
- Caris Life Sciences, Inc. (CAI) last traded around $15.94 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does CAI have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for CAI. Download the app for real-time alerts.
- How can I analyze Caris Life Sciences, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.